Glycosylation Gap in Patients with Diabetes with Chronic Kidney Disease and Healthy Participants: A Comparative Study

Aim: The aim of this study it to determine the level of glycosylation gap in patients with type 2 diabetes and its relation with kidney dysfunction. Materials and Methods: In this study, 150 individuals were enrolled (aged 20–75 year) and divided into three groups. Group 1 included 50 nondiabetic individuals who served as control. Group 2 included 50 patients with type 2 diabetes without chronic kidney disease (CKD), and in Group 3, there were 50 patients with type 2 diabetes with CKD. Glycated hemoglobin (HbA1c) and fructosamine (FA) were measured in all groups to determine the glycosylation gap (GG), predicted HbA1c, and mean blood glucose (MBG). GG is defined as the difference between measured HbA1c and HbA1c predicted from FA based on the population regression of HbA1c on FA. The variables were compared by correlation analysis. Results: Serum creatinine level was significantly high in patients with CKD (1.93 ± 0.99) as compared to patients with diabetes and control (0.891 ± 0.16; 0.912 ± 0.1), respectively. The study demonstrated a significant elevation in serum FA, measured HbA1c and predicted HbA1c, MBG in patients with diabetes with CKD as compared with those of without CKD, and controls. GG was found in healthy control (0.51 ± 0.78), patients with type 2 diabetes without CKD (0.62 ± 0.45), and patients with diabetes with CKD (1.0 ± 0.91), respectively. Conclusion: It is concluded that GG may be a useful clinical research tool for evaluating pathological source of variation in diabetes complications such as kidney disease.

[1]  Mohammad Abdul Gafoor Al kataan.  Glycosylation gap in a group obese subjects , 2013 .

[2]  J. Ahmad,et al.  Amadori albumin in diabetic nephropathy , 2015, Indian journal of endocrinology and metabolism.

[3]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[4]  E. Kilpatrick.  Problems in the assessment of glycaemic control in diabetes mellitus , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[5]  S. Taş,et al.  Automated fructosamine assay with improved accuracy used to quantify nonenzymatic glycation of serum proteins in diabetes mellitus and chronic renal failure. , 1990, Clinical chemistry.

[6]  D. Singer,et al.  The clinical information value of the glycosylated hemoglobin assay. , 1984, The New England journal of medicine.

[7]  Jean-Charles Sanchez,et al.  Strategies for proteomic analysis of non-enzymatically glycated proteins. , 2009, Mass spectrometry reviews.

[8]  J. Navarro,et al.  Diabetes, Inflammation, Proinflammatory Cytokines, and Diabetic Nephropathy , 2006, TheScientificWorldJournal.

[9]  R. Swaminathan,et al.  Fructosamine measurements in serum and plasma. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[10]  A. Cerami,et al.  Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. , 1976, The New England journal of medicine.

[11]  M Hørder,et al.  Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus. , 1990, The New England journal of medicine.

[12]  C. Mussini,et al.  Fructosamine and glycated hemoglobin as indices of glycemic control in patients with liver cirrhosis , 1990, La Ricerca in clinica e in laboratorio.

[13]  R. Cohen,et al.  Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. , 2003, Diabetes care.

[14]  A. Nevill,et al.  Evidence for Consistency of the Glycation Gap in Diabetes , 2011, Diabetes Care.

[15]  M. Rocco,et al.  Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[16]  J. Shield,et al.  Fructosamine and glycated haemoglobin in the assessment of long term glycaemic control in diabetes. , 1994, Archives of disease in childhood.

[17]  P. Pozzilli,et al.  Glucose control in diabetes , 2004, Diabetes/metabolism research and reviews.

[18]  J. Solski,et al.  Level of glycation gap in a healthy subject. , 2012, Annals of agricultural and environmental medicine : AAEM.

[19]  M. Haneda,et al.  Progression of diabetic nephropathy. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  B. Ettinger,et al.  Comparison of serum fructosamine vs glycohemoglobin as measures of glycemic control in a large diabetic population , 1998, Acta Diabetologica.